CVR: 32289290
Secondary names: VPN ApS, XGX ApS, XGX-Pharma ApS
XGX Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens-Nikolaj Schøier. The company is owned by Unimedic Pharma AB. The company has 2 employees. In 2025, the company reported a gross profit of DKK 32,338,381 and a net result of DKK 16,074,119 compared with DKK 4,453,433 the year before. Equity amounted to DKK 30,787,180.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med fremstilling, markedsføring og distribution af medicinske produkter samt at udøve enhver aktivitet, der efter ledelsens skøn er forbundet hermed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 32.3 mio. | 16.1 mio. | 55.1 mio. | 30.8 mio. | 0 | |
| 2024 | 16 mio. | 4.5 mio. | 39 mio. | 18.7 mio. | 4 | |
| 2023 | 8.1 mio. | 461 t. | 29.6 mio. | 14.3 mio. | 5 | |
| 2022 | 2.9 mio. | -1.8 mio. | 27.6 mio. | 13.8 mio. | 4 | |
| 2021 | 14.5 mio. | 7.2 mio. | 21.3 mio. | 13.2 mio. | 3 | |
| 2020 | 15.2 mio. | 6 mio. | 24.9 mio. | 12.9 mio. | 3 | |
| 2019 | 11.7 mio. | 8.4 mio. | 18.8 mio. | 11.4 mio. | 3 | |
| 2018 | 1.6 mio. | 27 t. | 3.5 mio. | 59 t. | 1 | |
| 2017 | 104 t. | -189 t. | 1.3 mio. | 32 t. | - | |
| 2016 | 307 t. | 272 t. | 877 t. | 92 t. | - | |
| 2015 | -33 t. | -35 t. | 900 t. | -180 t. | - | |
| 2014 | - | -14 t. | 466 t. | -145 t. | - | |
| 2013 | 145 t. | 145 t. | 14 t. | 130 t. | - | |
| 2012 | 84 t. | 96 t. | 66 t. | -14 t. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 412 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
Screen owners and management against the Danish FSA's official PEP lists
XGX Pharma ApS has published its annual report for 2025. Gross profit came to DKK 32,338,381, and the net result was DKK 16,074,119.
XGX Pharma ApS has won the tender "Udbudsnummer 1" issued by Amgros I/S worth 19,794,473 DKK.
As of July 21, 2025, KPMG P/S has been appointed auditor of XGX Pharma ApS.
As of July 21, 2025, Kreston CM Statsautoriseret Revisions interessentskab has stepped down as auditor of XGX Pharma ApS.
As of July 21, 2025, Per Anders Larnholt has joined the board of directors of XGX Pharma ApS.
As of July 21, 2025, Johan Frödin has joined the board of directors of XGX Pharma ApS.
As of July 21, 2025, Mohammad Sohail Asghar has left the board of directors of XGX Pharma ApS.
As of July 21, 2025, Lars Karlsmose has left the board of directors of XGX Pharma ApS.
As of July 21, 2025, Jens-Nikolaj Schøier has left the board of directors of XGX Pharma ApS.
As of July 21, 2025, is registered as an owner of XGX Pharma ApS with an ownership share of 100%.
XGX Pharma ApS has published its annual report for 2024. Gross profit came to DKK 16,033,793, and the net result was DKK 4,453,433.
XGX Pharma ApS has published its annual report for 2023. Gross profit came to DKK 8,100,823, and the net result was DKK 460,891.
XGX Pharma ApS has published its annual report for 2022. Gross profit came to DKK 2,917,678, and the net result was DKK -1,842,554.
XGX Pharma ApS has published its annual report for 2021. Gross profit came to DKK 14,515,287, and the net result was DKK 7,248,505.
As of May 10, 2022, Mohammad Sohail Asghar has joined the board of directors of XGX Pharma ApS.
As of May 10, 2022, Rolf Eckersberg has left the board of directors of XGX Pharma ApS.
As of May 9, 2022, Mohammad Sohail Asghar has left the board of directors of XGX Pharma ApS.
XGX Pharma ApS has published its annual report for 2020. Gross profit came to DKK 15,225,623, and the net result was DKK 6,004,347.
XGX Pharma ApS has published its annual report for 2019. Gross profit came to DKK 11,716,951, and the net result was DKK 8,356,668.
As of February 14, 2020, Kreston CM Statsautoriseret Revisions interessentskab has been appointed auditor of XGX Pharma ApS.
As of February 14, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of XGX Pharma ApS.
As of January 27, 2020, Rolf Eckersberg has joined the board of directors of XGX Pharma ApS.
As of January 27, 2020, Per Ludvigsen has left the board of directors of XGX Pharma ApS.
As of November 22, 2019, Lars Karlsmose has joined the board of directors of XGX Pharma ApS.
XGX Pharma ApS has published its annual report for 2018. Gross profit came to DKK 1,574,797, and the net result was DKK 26,878.
As of November 1, 2018, Mohammad Sohail Asghar has joined the board of directors of XGX Pharma ApS.
As of November 1, 2018, Per Ludvigsen has joined the board of directors of XGX Pharma ApS.
As of November 1, 2018, Jens-Nikolaj Schøier has joined the board of directors of XGX Pharma ApS.
XGX Pharma ApS has published its annual report for 2017. Gross profit came to DKK 104,432, and the net result was DKK -189,057.
As of December 1, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of XGX Pharma ApS.
As of December 1, 2017, Jens-Nikolaj Schøier is registered as adm. dir. of XGX Pharma ApS.
As of December 1, 2017, Mohammad Sohail Asghar has stepped down as director of XGX Pharma ApS.
XGX Pharma ApS has published its annual report for 2016. Gross profit came to DKK 307,092, and the net result was DKK 271,902.
XGX Pharma ApS has published its annual report for 2015. Gross profit came to DKK -32,643, and the net result was DKK -34,858.
XGX Pharma ApS has published its annual report for 2014. The net result was DKK -14,436.
As of June 23, 2015, REVISIONSFIRMAET WOIREMOSE & PARTNER REGISTRERET REVISIONSANPARTSSELSKAB has stepped down as auditor of XGX Pharma ApS.
As of May 15, 2015, REVISIONSFIRMAET WOIREMOSE & PARTNER REGISTRERET REVISIONSANPARTSSELSKAB has been appointed auditor of XGX Pharma ApS.
As of May 15, 2015, Kreston CM Statsautoriseret Revisions interessentskab has stepped down as auditor of XGX Pharma ApS.
XGX Pharma ApS has published its annual report for 2013. Gross profit came to DKK 144,613, and the net result was DKK 144,707.
XGX Pharma ApS has published its annual report for 2012. Gross profit came to DKK 83,774, and the net result was DKK 96,450.
As of July 14, 2009, Kreston CM Statsautoriseret Revisions interessentskab has been appointed auditor of XGX Pharma ApS.
As of July 14, 2009, Mohammad Sohail Asghar is registered as director of XGX Pharma ApS.
XGX Pharma ApS was founded on July 14, 2009.
Companies in the same industry and area
CVR 41183144
CVR 35451307
CVR 36392398
CVR 37626619
CVR 19835081
companydata.dk